WSJ Sues to Gain Access to Medicare Database
The filing by Dow Jones & Co., in the U.S. District Court for the Middle District of Florida, comes after a series of articles in the Journal about abuses of the Medicare system.
The filing by Dow Jones & Co., in the U.S. District Court for the Middle District of Florida, comes after a series of articles in the Journal about abuses of the Medicare system.
The Coalition Against Bayer pharmaceuticals (CBG) announces that Bayer and Baxter settled a mulit-million dollar compensation suit with hemophiliacs in 22 countries who were victims, infected with HIV or hepatitis C having been infused with tainted blood plasma products in the 1980s. In 2003, The New York Times reported that…
"Despite ongoing controversy, there has never been a large-scale, prospective study of the cognitive effects of electroconvulsive therapy (ECT)." Dr. Harold Sackeim, et al, 2007.
America’s health care expenditure is about to go through the roof–without improving anyone’s health!
Public concerns about vaccine safety are well-grounded in reality.
"the prevailing medical opinion is that vaccines are scientifically linked to encephalopathy, but not scientifically linked to autism."
Those who rail against government regulation in healthcare must consider the potential consequences.
A fascinating article in The Atlantic, "Lies, Damned Lies, and Medical Science" by David Freedman, profiles Dr. John Ioannidis, who says that as much as 90% of the published medical information that doctors rely on is flawed.
TAKE ACTION! Help rescind proposed firing of FDA scientist
The excerpts from The New Yorker (below) may be read as a companion piece to the Atlantic article profiling Dr. John Ioannidis. However, the opening example that Lehrer uses to make the point that initial impressive positive research findings often weaken in time, perpetuates a myth about the new…
Why does the Obama administration shield PhRMA companies against lawsuits by public hospitals and clinics that have been overcharged for drugs in violation of a federal law mandating reduced drug prices for clinics and hospitals that serve the poor?
Topical tacrolimus and pimecrolimus: cancer, infections—"a clearly unfavorable benefit-risk ratio"— Prescrire International 2010 ; 19 (110) : 257 English edition.